ArticleBMC nephrology2022

Real-world assessment: effectiveness and safety of extended-release calcifediol and other vitamin D therapies for secondary hyperparathyroidism in CKD patients.

Michael J Germain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.